{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T13:25:02Z","timestamp":1786886702009,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,9]],"date-time":"2027-04-09T00:00:00Z","timestamp":1807228800000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY010804"],"award-info":[{"award-number":["R01EY010804"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS094522\\u201301"],"award-info":[{"award-number":["1R01NS094522\\u201301"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS120028\\u201301"],"award-info":[{"award-number":["1R21NS120028\\u201301"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["25R01"],"award-info":[{"award-number":["25R01"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["25K09"],"award-info":[{"award-number":["25K09"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000183","name":"US Army Research Office","doi-asserted-by":"publisher","award":["W911NF-21-1-0248"],"award-info":[{"award-number":["W911NF-21-1-0248"]}],"id":[{"id":"10.13039\/100000183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Foundation","doi-asserted-by":"publisher","award":["2012\/R\/2"],"award-info":[{"award-number":["2012\/R\/2"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Foundation","doi-asserted-by":"publisher","award":["2015\/R\/07"],"award-info":[{"award-number":["2015\/R\/07"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001013","name":"Buoniconti Fund to Cure Paralysis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cyto.2026.157152","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:34:35Z","timestamp":1775788475000},"page":"157152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Generation and characterization of the TRE-TNFR2 transgenic mouse for cell-specific and timed (over)expression of tumor necrosis factor receptor 2"],"prefix":"10.1016","volume":"202","author":[{"given":"Placido","family":"Illiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadee","family":"Nissanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen C.","family":"Ascona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haritha L.","family":"Desu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna N.","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwetha","family":"Mudalegundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Liebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos T.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2026.157152_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2026.157152_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.cyto.2026.157152_bb0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10571-022-01229-0","article-title":"The role of tumor necrosis factor following spinal cord injury: a systematic review","volume":"43","author":"Lund","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.cyto.2026.157152_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157152_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112603","article-title":"Tumor necrosis factor receptor 2 (TNFR2): an emerging target in cancer therapy","volume":"14","author":"Medler","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cyto.2026.157152_bb0030","doi-asserted-by":"crossref","first-page":"2326694","DOI":"10.1080\/2162402X.2024.2326694","article-title":"Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer","volume":"13","author":"Dickey","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cyto.2026.157152_bb0035","doi-asserted-by":"crossref","first-page":"1209188","DOI":"10.3389\/fimmu.2023.1209188","article-title":"Therapeutic potential of TNFR2 agonists: a mechanistic perspective","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157152_bb0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","article-title":"TNFR2: a novel target for cancer immunotherapy","volume":"23","author":"Vanamee","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cyto.2026.157152_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbi.2024.09.002","article-title":"TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease","volume":"123","author":"Desu","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cyto.2026.157152_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbi.2019.11.017","article-title":"Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling","volume":"84","author":"Madsen","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.cyto.2026.157152_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.celrep.2016.11.083","article-title":"Opposing functions of microglial and macrophagic TNFR2 in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"18","author":"Gao","year":"2017","journal-title":"Cell Rep."},{"issue":"18","key":"10.1016\/j.cyto.2026.157152_bb0060","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1523\/JNEUROSCI.0211-16.2016","article-title":"Oligodendroglial TNFR2 mediates membrane TNF-dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination","volume":"36","author":"Madsen","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cyto.2026.157152_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbi.2023.12.025","article-title":"Microglial TNFR2 signaling regulates the inflammatory response after CNS injury in a sex-specific fashion","volume":"116","author":"Raffaele","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cyto.2026.157152_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbi.2025.07.006","article-title":"Astroglial TNFR2 signaling regulates hippocampal synaptic function and plasticity in a sex dependent manner","volume":"129","author":"Carney","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"13","key":"10.1016\/j.cyto.2026.157152_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014043118","article-title":"Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing treg cells","volume":"118","author":"Ronin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"51","key":"10.1016\/j.cyto.2026.157152_bb0080","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.1807499115","article-title":"Intrinsic TNFR2 signaling in t regulatory cells provides protection in CNS autoimmunity","volume":"115","author":"Atretkhany","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cyto.2026.157152_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molcel.2013.04.018","article-title":"Chromatin insulators: linking genome organization to cellular function","volume":"50","author":"Phillips-Cremins","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cyto.2026.157152_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbi.2024.09.002","article-title":"TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease","volume":"123","author":"Desu","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.cyto.2026.157152_bb0095","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/hmg\/ddn437","article-title":"Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons","volume":"18","author":"Fukui","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"5293","key":"10.1016\/j.cyto.2026.157152_bb0100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.274.5293.1678","article-title":"Control of memory formation through regulated expression of a CaMKII transgene","volume":"274","author":"Mayford","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cyto.2026.157152_bb0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/dvg.20808","article-title":"Gene induction in mature oligodendrocytes with a PLP-tTA mouse line","volume":"50","author":"Inamura","year":"2012","journal-title":"Genesis"},{"issue":"42","key":"10.1016\/j.cyto.2026.157152_bb0110","doi-asserted-by":"crossref","first-page":"10185","DOI":"10.1523\/JNEUROSCI.1378-17.2017","article-title":"Mitochondrial DNA double-strand breaks in oligodendrocytes cause demyelination, axonal injury, and CNS inflammation","volume":"37","author":"Madsen","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2026.157152_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12974-021-02200-4","article-title":"Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKbeta promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice","volume":"18","author":"Papazian","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2026.157152_bb0120","article-title":"Targeting TNFR2: a novel breakthrough in the treatment of cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2026.157152_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121952","article-title":"The roles of TNFR2 signaling in cancer cells and the tumor microenvironment and the potency of TNFR2 targeted therapy","volume":"11","author":"Takahashi","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cyto.2026.157152_bb0130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-221230","article-title":"Activation of TNF receptor 2 improves synaptic plasticity and enhances amyloid-beta clearance in an alzheimer\u2019s disease mouse model with humanized TNF receptor 2","volume":"94","author":"Orti-Casan","year":"2023","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.cyto.2026.157152_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888274","article-title":"A TNFR2-specific TNF fusion protein with improved in vivo activity","volume":"13","author":"Vargas","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157152_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008898","article-title":"TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated treg and reducing t cell exhaustion","volume":"12","author":"Debesset","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.cyto.2026.157152_bb0145","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/JLB.5MA0420-375RRRRR","article-title":"TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models","volume":"107","author":"Case","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.cyto.2026.157152_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108931","article-title":"Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cyto.2026.157152_bb0155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10753-020-01188-y","article-title":"Immunomodulatory effect of doxycycline ameliorates systemic and pulmonary inflammation in a murine polymicrobial sepsis model","volume":"43","author":"Patel","year":"2020","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.cyto.2026.157152_bb0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","article-title":"Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways","volume":"29","author":"Santa-Cecilia","year":"2016","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.cyto.2026.157152_bb0165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-024-03218-1","article-title":"Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer","volume":"43","author":"Mussa","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cyto.2026.157152_bb0170","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1158\/2159-8290.CD-22-1046","article-title":"Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer","volume":"13","author":"Bianchi","year":"2023","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.cyto.2026.157152_bb0175","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Invest."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:38:06Z","timestamp":1786883886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S1043466626000475"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157152","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of the TRE-TNFR2 transgenic mouse for cell-specific and timed (over)expression of tumor necrosis factor receptor 2","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157152"}}